This article explains how global pharmaceutical regulations define GMP compliance expectations, inspection frameworks, and quality system maturity. It highlights regulatory inspection readiness pharma, data integrity systems, and compliance risk management shaping modern pharmaceutical regulatory environments and inspection outcomes.
